We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04681820
Brief Title: Evaluating Efficacy and Safety of Flumatinib Versus Nilotinib for Chronic Phase Chronic Myeloid Leukemia(CML-CP) Without Optimal Response (Warning,Failure) to Imatinib or Dasatinib

First Submitted : December 18, 2020
First Submitted that Met QC Criteria : December 18, 2020
First Posted : December 23, 2020

Last Update Submitted that Met QC Criteria : May 31, 2021
Last Update Posted : June 3, 2021